Hunan Warrant Pharmaceutical Co.,Ltd.’s Net Profit Rose 26.5% in First Half of 2023

Hunan Warrant Pharmaceutical Co.,Ltd. (湖南华纳大药厂股份有限公司) (688799.SH) reported a net profit of 103.3 million yuan in the first half of 2023, up 26.5% year-on-year.

Meanwhile, the company posted 721.1 million yuan in revenue, up 21.7% year-on-year.

At the end of the reporting period, it had 2.1 billion yuan in total assets and 334.9 million yuan in total liabilities, with a liability-to-asset ratio of 16%.